Publication | Closed Access

Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes

Tgfb1 HaplotypesBreast OncologyPromoter Region PolymorphismGenetic EpidemiologyPathologyBreast CancerClinicopathological FeaturesCancer GeneticsMedicineRadiation OncologyCancer ResearchCancer Growth